Ranbaxy Laboratories

Rediff.com » News » Ranbaxy Laboratories

News for Ranbaxy Laboratories

Business

Lessons from the Fortis/Raymond family feuds

'Nothing in this world is permanent. So also in business.''And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.......

Fisticuffs in Fortis family as Singhs accuse each other of assault

Former Fortis and Ranbaxy promoters Malvinder Singh and Shivinder Mohan Singh reportedly came to blows in the latest turn to their ongoing feud. In a video posted on social media, Malvinder......

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Sun Pharma’s market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013. The country’s leading drug maker......

How the private sector has stalled India's reforms

'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan. Illustration: Uttam Ghosh/Rediff.com It used to be......

Fortis shareholders vote out director, shadow over sale

Fortis Healthcare on Wednesday said its shareholders have voted in favour of the removal of Brian Tempest from the board of directors in the company's extraordinary general meeting held on......

Rediff News

Ranbaxy Laboratories

News for Ranbaxy Laboratories

Lessons from the Fortis/Raymond family feuds

Fisticuffs in Fortis family as Singhs accuse each other of assault

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

How the private sector has stalled India's reforms

Fortis shareholders vote out director, shadow over sale

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS